Kymera Therapeutics, Inc.
KYMRAs of the close on Sep 25, 2026
Price
$111.95
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$3.25
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Kymera Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 15,951 | $1.33M | SEC filing |
| Marquette Asset Management, LLC | 2026-03-31 | 6 | $500 | SEC filing |
| KENNEDY CAPITAL MANAGEMENT LLC | 2026-03-31 | 13,661 | $1.14M | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 83,876 | $6.99M | SEC filing |
| Keudell/Morrison Wealth Management | 2026-03-31 | 6,990 | $582K | SEC filing |
| Commodore Capital LP | 2026-03-31 | 750,000 | $62.5M | SEC filing |
| Truvestments Capital LLC | 2026-03-31 | 213 | $17.7K | SEC filing |
| Proficio Capital Partners LLC | 2026-03-31 | 10,845 | $903K | SEC filing |
| GUGGENHEIM CAPITAL LLC | 2026-03-31 | 13,088 | $1.09M | SEC filing |
| CWM, LLC | 2026-03-31 | 378 | $31.5K | SEC filing |
| Capital Research Global Investors | 2026-03-31 | 1,673,275 | $139M | SEC filing |
| BESSEMER GROUP INC | 2026-03-31 | 928 | Not shown | SEC filing |
| Bare Financial Services, Inc | 2026-03-31 | 25 | $2.08K | SEC filing |
| Swiss Life Asset Management Ltd | 2026-03-31 | 2,645 | $220K | SEC filing |
| HighVista Strategies LLC | 2026-03-31 | 3,785 | $315K | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 3,710 | $309K | SEC filing |
| BRAIDWELL LP | 2026-03-31 | 337,559 | $28.1M | SEC filing |
| FMR LLC | 2026-03-31 | 11,699,950 | $974M | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 25,403 | $2.12M | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 3,163 | Not shown | SEC filing |
- Each value is checked against Kymera Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Kymera Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Kymera Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-26 · Booth Bruce: Larger than 167 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Booth Bruce: Larger than 166 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Booth Bruce: Larger than 164 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Booth Bruce: Larger than 163 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Booth Bruce: Larger than all 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-25 · Booth Bruce: Larger than 179 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-25 · Booth Bruce: Larger than 173 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-25 · Booth Bruce: Larger than 169 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-25 · Booth Bruce: Larger than 168 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-25 · Booth Bruce: Larger than 176 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-24 · Booth Bruce: Larger than 178 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-22 · Booth Bruce: Larger than 162 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-22 · Booth Bruce: Larger than 172 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-22 · Booth Bruce: Larger than 170 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-18 · Booth Bruce: Larger than 174 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-18 · Booth Bruce: Larger than 165 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-06-17 · Booth Bruce: Larger than 177 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-03-23 · Chadwick Jeremy G: Larger than 171 of the 180 other insider sales of Common Stock on file. SEC filing
- 2026-03-02 · Booth Bruce: Larger than 175 of the 180 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −5,471 | 105.78 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −1,239 | 109.75 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −1,199 | 110.67 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −7,602 | 110.67 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −14,613 | 106.63 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −2,318 | 106.63 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −3,024 | 107.76 | SEC filing |
| 2026-06-29 | Booth Bruce · Director | Common Stock | S — Open market or private sale | −7,833 | 109.75 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Goodman Noah · Chief Business Officer | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-06-25 | Goodman Noah · Chief Business Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-06-24 | BAKER JULIAN · Director, 10% owner | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
| 2026-06-24 | Hrustanovic Gorjan · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
| 2026-06-24 | Albers Jeffrey W. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
| 2026-06-24 | Esposito Pamela · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
| 2026-06-24 | Booth Bruce · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
| 2026-06-24 | MARAGANORE JOHN · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +6,068 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.